> Blulux Laboratories Pvt. Ltd.

CAS # 6119-70-6 QUININE SULFATE AR

Blulux Laboratories Pvt. Ltd
79/66-B, I.H.I.Complex, H/W Chowk Industrial Area, N.I.T. Faridabad - 1, Haryana (India)
Tel. : + 91 129 4021360, 4190300 
Fax : + 91 129 4190333
E-mail: bluluxlab@gmail.com  Website : www.blulux.com


 

HAZARD IDENTIFICATION
==============================================================================
Route Of Entry Inds - Inhalation: YES Skin: YES Ingestion: YES
Carcinogenicity Inds - NTP: NO IARC: NO OSHA: NO

Health Hazards Acute And Chronic: ACUTE: INHAL: NO DATA AVAIL. DUST MAY CAUSE IRRIT. SKIN: NO DATA AVAIL. QUININE IS MARKED LOC IRRITANT & ANESTH. SENSORY NERVES ARE BRIEFLY STIMULATED THAN PARALYZED. CONCS ONLY SLIGHTLY HIGHER THAN THOSE NEC FOR ANESTH ARE LIKELY TO CAUSE EDEMA, PAIN & REACTIVE FIBROSIS. ANESTH MAY LAST MANY HRS/DAYS. EYES: NO DATA AVAIL. QUININE IS MARKED LOC IRRITANT & ANESTH. INGEST: SINGLE LG DOSES MAY CAUE FOLLOWING SYMPS, ANY ONE/GROUP OF WHICH MAY REPRESENT SYNDROME KNOWN AS "CINCHON ISM" OR HYPERSENS RXN. HEMATOLOGIC SYMPS MAY INCL ACUTE HEMOLYSIS, THROMBOCYTOPENIC PURPURA, AGRANULOCYTOSIS & HYPOPROTHROMBINEMIA. CNS EFTS (EFTS OF OVEREXP)

Explanation of Carcinogenicity: N/P

Signs and Symptoms of Overexposure: EFTS OF OVEREXP: HYPOTENSION & CARD ARREST POSS. DEATHS REPORTED FROM 1.5-8.0G OF QUININE, ALTHOUGH MUCH LARGER DOSES TOLERATED. DELIRIUM, COMA/CONVLS MAY OCCUR TERMINALLY. DEATH MAY OCCUR W/IN FEW HRS/BE DELAYED 1-2 DAYS. PERS RECOVERING F ROM LG AMTS MAY HAVE RESIDUAL OPTIC & AUDITORY DMG. LG DOSES (UP TO 30G) IN PREGNANT WOMEN HAVE RSLTD IN CONGENITAL MALFORMATIONS INCL DEAFNESS RELATED TO AUDITORY NERVE HYPOPLASIA, LIMB ANOMALITIES, VISCERAL DEFECTS & VISUAL CHGS. CHRONIC: INHAL:NO DATA VAIL AS TO WHETHER RPTD EXPOS MAY RSLT IN "CINCHONIMS" W/SYMPS AS DESCRIBED IN INGEST. SKIN CNTCT: MAY CAUSE DERM. (SUPDAT)

Medical Conditions Aggravated by Overexposure: N/P

==============================================================================
FIRST AID
==============================================================================
INHAL: REMOVE TO FRESH AIR IMMED. IF BRTHG STOPS, PERFORM ARTF RESP. KEEP WARM & AT REST. TREAT SYMP & SUPPORTIVELY. GET MED ATTN IMMED. SKIN: REMOVE CONTAM CLTHG & SHOES IMMED. WASH AFFECTED AREA W/SOAP OR MILD DETERGENT & LG AMTS OF WATER UNTIL NO EVID OF CHEM REMAINS (APPROX 15-20 MIN). GET MED ATTN IMMED. EYES: WASH IMMED W/LG AMTS OF WATER OR NORM SALINE, OCCASNLY LIFTING UPPER & LOWER LIDS UNTIL NO EVID OF CHEM REMAINS (AT LEST 15-20 MIN). GET MED ATTN IMMED. INGEST: RE MOVE BY GASTRIC LAVAGE OR EMESIS. MAINTAIN BLOOD PRESS & AIRWAY. GIVE OXYG IF RESP IS DEPRESSED. DO NOT PERFORM GASTRIC (OTHER INFO)

==============================================================================
FIRE FIGHTING MEASURES
==============================================================================
Flash Point Text: N/P

Auto Ignition Temperature Text: 

Extinguishing Media: DRY CHEM, CARBON DIOXIDE, HALON, WATER SPRAY OR STANDARD FOAM. FOR LARGER FIRES, USE WATER SPRAY, FOG OR STANDARD FOAM. (1987 EMERGENCY RESPONSE GUIDEBOOK, DOT P 5800.4).

Fire Fighting Procedures: USE NIOSH APPROVED SCBA AND FULL PROTECTIVE EQUIPMENT (FP N). NO ACUT HAZARD. MOVE CONTAINER FROM FIRE AREA IF POSSIBLE. AVOID BREATHING VAPORS OR DUSTS; KEEP UPWIND.

Unusal Fire/Explosion Hazard: NEGLIGIBLE FIRE HAZARD WHEN EXPOSED TO HEAT OR FLAME. NFPA RATINGS (SCALE 0-4): HEALTH=3; FIRE=0; REACTIVITY=0.

==============================================================================
RELEASE MEASURES
==============================================================================
Spill Release Procedures: SWEEP UP AND PLACE IN SUITABLE (FIBERBOARD) CONTAINERS FOR RECLAMATION OR LATER DISPOSAL.
Neutralizing Agent: N/P

Waste Disposal Methods: DISPOSAL MUST BE IN ACCORDANCE WITH FEDERAL, STATE AND LOCAL REGULATIONS (FP N).

==============================================================================
HANDLING AND STORAGE
==============================================================================
MAY BURN BUT DOES NOT IGNITE READILY. AVOID CONTACT WITH STRONG OXIDIZERS, EXCESSIVE HEAT, SPARKS OR OPEN FLAMES.

==============================================================================
EXPOSURE CONTROLS/PERSONAL PROTECTION
==============================================================================
Respiratory Protection: FOLLOWING RESPS RECOM BASED ON INFO FOUND IN PHYSICAL DATA, TOX & HLTH EFTS SECTIONS. RANKED IN ORDER FROM MIN TO MAX RESP PROT. RESP SELECTED MUST BE BASED ON CONTAM LEVELS FOUND IN WORK PLACE, MUST NOT EXCEED WORKING LIMS OF RESP & BE NIO SH APPRVD. CHEM CARTRIDGE RESP W/FULL FACEPIECE & ORG VAP CARTRIDGE(S) IN COMBINATION W/DUST & (OTHER INFO)
Ventilation: PROVIDE LOCAL EXHAUST OR PROCESS ENCLOSURE VENTILATION SYSTEM.
Protective Gloves: IMPERVIOUS GLOVES (FP N).
Eye Protection: ANSI APPROVED CHEMICAL WORKERS GOGGLES (FP N).
Other Equipment: EMERGENCY EYE WASH & DELUGE SHOWER MEETING ANSI DESIGN CRITERIA (FP N). APPROP PROT (IMPERVIOUS) CLTHG & EQUIP TO PREVENT RPTD OR PRLNGD SKIN CONTACT W/THIS SUBSTANCE.
Work Hygenic Practices: EMERGENCY EYE WASH & DELUGE SHOWER MEETING ANSI DESIGN CRITERIA (FP N). APPROP PROT (IMPERVIOUS) CLTHG & EQUIP TO PREVENT RPTD OR PRLNGD SKIN CONTACT W/THIS SUBSTANCE.
Supplemental Safety & Health: EFTS OF OVEREXP: EYES:NO DATA AVAIL. INGEST:RPTD EXPOS MAY CAUSE "CINCHONISM" CHARACT BY TINNUITUS, HDCH, VERTIGO, NAUS & DISTURBED VISION W/BILATERAL DILATED PUPILS, PALLOR OF OPTIC DISKS, NARROWING OF RETINAL VESSELS, PAPILLEDEMA & LATE C ONSTRICTION OF VISUAL FIELDS. IF CONTINUED, SYMPS MAY ALSO INVOLVE (OTHER INFO)

==============================================================================
PHYSICAL AND CHEMICAL PROPERTIES
==============================================================================
Boiling Point: 
N/P
Melting/Freezing Point: =205.C, 401.F

Decomposition Temp: 
N/P
Vapor Pressure: N/P Vapor Density: N/P
Specific Gravity: NOT AVAIL
PH: 6.2 @ SATD SOLN
Viscosity: N/P
Evaporation Rate & Reference: N/P
Solubility in Water: 0.12-0.2%
Appearance and Odor: ODORLESS, SILKY, WHITE POWDER OR FINE CRYSTALS WHICH BECOME (TRANSPORT INFO)
Percent Volatiles by Volume: N/P
Corrosion Rate: N/P

==============================================================================
STABILITY AND REACTIVITY
==============================================================================
Stability Indicator: YES
Stability Conditions to Avoid: STABLE UNDER NORMAL TEMPERATURES AND PRESSURES.
Materials to Avoid: QUININE SULFATE: NONE KNOWN.
Hazardous Decomposition Products: THERMAL DECOMPOSITION MAY RELEASE TOXIC OXIDES OF NITROGEN AND SULFUR.
Hazardous Polymerization Products: NO
Conditions to Avoid Polymerization: N/P

==============================================================================
TOXICOLOGICAL
==============================================================================
QUININE SULFATE, DIHYDRATE: CARCIN STATUS: NONE. POISONING MAY EFT SKIN, BLOOD & GI, RESP, CVS & NERVOUS SYSTEMS, PARTICULARLY W/EFTS ON VISION & HEARING. PERS W/GLUCOSE-6-PD DEFICIENCY MAY BE AT INCREASED RISK FROM EXPOS DUE TO SUSCEPTIBI LITY TO HEMOLYSIS. CONCURRENT USE OF THIS SUBSTANCE W/OTHER VARIOUS DRUGS MAY CAUSE ADVERSE EFTS AS NOTED. QUININE TOX MAY BE ENHANCED BY FOODS/DRUGS THAT ALKALINIZE URINE THUS INCREASING RENAL ABSORPTION. ADDITIVE EFT MAY OCCUR W/CENTRALL Y & PERIPHERALLY ACTING ANTICHOLINERGICS. BONE MARROW DEPRESS ADDITIVE EFT MAY OCCUR W/MYELOSUPPRESSANTS, INCLUDING RADIA THERAPY. ADDITIVE (TRANSPORT)

==============================================================================
ECOLOGICAL
==============================================================================
OTHER INFO: PARTICULATE FILTER. POWERED AIR-PURIFYING RESP W/TIGHT-FITTING FACEPIECE & ORG VAP CARTRIDGE(S) IN COMBINATION W/HIGH-EFFICIENCY PARTICULATE FILTER. TYPE 'C' SUPPLIED-AIR RESP W/FULL FACEPIECE OPERATED IN PRESS-DEMAND OR OTHER P OS PRESS MODE OR W/FULL FACEPIECE, HELMET/HOOD OPERATED IN CONTINUOUS-FLOW MODE. SCBA W/FULL FACEPIECE OPERATED IN PRESS-DEMAND OR OTHER POS PRESS MODE. FIREFIGHTING & OTHER IMMED DANGEROUS TO LIFE/HEALTH CNDTNS: SCBA W/FULL FACEPIECE OPERA TED IN PRESS-DEMAND OR OTHER POS PRESS MODE. SUPPLIED-AIR RESP W/FULL FACEPIECE & OPERATED IN PRESS-DEMAND OR OTHER POS PRESS MODE IN COMBINATION (TRANSPORT)

==============================================================================
DISPOSAL
==============================================================================
DISPOSAL MUST BE IN ACCORDANCE WITH FEDERAL, STATE AND LOCAL REGULATIONS (FP N).

==============================================================================
TRANSPORTATION
==============================================================================
CONTACT Blulux Laboratories Pvt. Ltd. COMPANY
==============================================================================
REGULATORY
==============================================================================
Federal Regulatory: Y
==============================================================================
OTHER
==============================================================================

 

Mfgs. & Exporters: Laboratory Reagents, Fine Chemicals, Analytical Reagents & Dehydrated Culture Media